Giulia Apprato

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 7

Top Topics

Reduced Graphene Oxide

Prostate Cancer

Top Venues

ACS medicinal chemistry letters

Molecules (Basel, Switzerland)

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Paolo Rossetti, Giulia Apprato, Giulia Caron, Giuseppe Ermondi, Matteo Rossi Sebastiano
DegraderTCM: A Computationally Sparing Approach for Predicting Ternary Degradation Complexes. ACS medicinal chemistry letters 15 (1) (2023)
Giulia Apprato, Giulia D'Agostini, Paolo Rossetti, Giuseppe Ermondi, Giulia Caron
In Silico Tools to Extract the Drug Design Information Content of Degradation Data: The Case of PROTACs Targeting the Androgen Receptor. Molecules (Basel, Switzerland) 28 (3) (2023)
Giulia Apprato, Giulia D'Agostini, Paolo Rossetti, Giuseppe Ermondi, Giulia Caron
In Silico Tools to Extract the Drug Design Information Content of Degradation Data: The Case of PROTACs Targeting the Androgen Receptor. Molecules (Basel, Switzerland) 28 (3) (2023)
Paolo Rossetti, Giulia Apprato, Giulia Caron, Giuseppe Ermondi, Matteo Rossi Sebastiano
DegraderTCM: A Computationally Sparing Approach for Predicting Ternary Degradation Complexes. ACS medicinal chemistry letters 15 (1) (2023)
Diego Garcia Jimenez, Maura Vallaro, Matteo Rossi Sebastiano, Giulia Apprato, Giulia D'Agostini, Paolo Rossetti, Giuseppe Ermondi, Giulia Caron
Chamelogk: A Chromatographic Chameleonicity Quantifier to Design Orally Bioavailable Beyond-Rule-of-5 Drugs. Journal of medicinal chemistry (2023)
Giulia Apprato, Giulia D'Agostini, Paolo Rossetti, Giuseppe Ermondi, Giulia Caron
In Silico Tools to Extract the Drug Design Information Content of Degradation Data: The Case of PROTACs Targeting the Androgen Receptor. Molecules (Basel, Switzerland) 28 (3) (2023)
Giulia Apprato, Giuseppe Ermondi, Giulia Caron
The Quest for Oral PROTAC drugs: Evaluating the Weaknesses of the Screening Pipeline. ACS medicinal chemistry letters 14 (7) (2023)